PMID- 29915435
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231112
IS  - 0027-7622 (Print)
IS  - 2186-3326 (Electronic)
IS  - 0027-7622 (Linking)
VI  - 80
IP  - 2
DP  - 2018 May
TI  - Lifestyle intervention using Internet of Things (IoT) for the elderly: A study 
      protocol for a randomized control trial (the BEST-LIFE study).
PG  - 175-182
LID - 10.18999/nagjms.80.2.175 [doi]
AB  - Modification of lifestyle habits, including diet and physical activity, is 
      essential for the prevention and control of type 2 diabetes mellitus (T2DM) in 
      elderly patients. However, individualized treatment is more critical for the 
      elderly than for general patients. This study aimed to determine lifestyle 
      interventions that resulted in lowering hemoglobin A(1c) (HbA(1c)) in Japanese 
      pre- and early diabetic elderly subjects. The BEST-LIFE trial is an ongoing, 
      open-label, 6-month, randomized (1:1) parallel group trial. Subjects with HbA(1c) 
      of >/=5.6%-randomly assigned to the intervention or control group -use wearable 
      monitoring devices loaded with Internet of things (IoT) systems that aids them 
      with self-management and obtaining monthly remote health guidance from a public 
      health nurse. The primary outcome is changes in HbA(1c) after a 6-month 
      intervention relative to the baseline values. The secondary outcome is the change 
      of behavior modification stages. The background, rationale, and study design of 
      this trial are also presented. One hundred forty-five subjects have already been 
      enrolled in this lifestyle intervention program, which will end in 2019. The 
      BEST-LIFE trial will provide new evidence regarding the effectiveness and safety 
      of our program on lowering HbA(1c) in elderly subjects with T2DM. It will also 
      investigate whether information communication technology tools and monitoring 
      devices loaded with IoT can support health care in elderly subjects. The trial 
      registration number is UMIN-CTR: UMIN 000023356.
FAU - Kato, Sawako
AU  - Kato S
AD  - Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, 
      Japan.
FAU - Ando, Masahiko
AU  - Ando M
AD  - Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, 
      Nagoya, Japan.
FAU - Kondo, Takaaki
AU  - Kondo T
AD  - Program in Radiological and Medical Laboratory Sciences, Nagoya University 
      Graduate School of Medicine, Nagoya, Japan.
FAU - Yoshida, Yasuko
AU  - Yoshida Y
AD  - Innovative Research Center for Preventative Medical Engineering, Nagoya 
      University, Nagoya, Japan.
FAU - Honda, Hiroyuki
AU  - Honda H
AD  - Innovative Research Center for Preventative Medical Engineering, Nagoya 
      University, Nagoya, Japan.
FAU - Maruyama, Shoichi
AU  - Maruyama S
AD  - Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, 
      Japan.
LA  - eng
PT  - Journal Article
PL  - Japan
TA  - Nagoya J Med Sci
JT  - Nagoya journal of medical science
JID - 0412011
PMC - PMC5995741
OTO - NOTNLM
OT  - behavior modification
OT  - elderly
OT  - internet of things
OT  - lifestyle intervention
OT  - type 2 diabetes
EDAT- 2018/06/20 06:00
MHDA- 2018/06/20 06:01
PMCR- 2018/05/01
CRDT- 2018/06/20 06:00
PHST- 2018/06/20 06:00 [entrez]
PHST- 2018/06/20 06:00 [pubmed]
PHST- 2018/06/20 06:01 [medline]
PHST- 2018/05/01 00:00 [pmc-release]
AID - 10.18999/nagjms.80.2.175 [doi]
PST - ppublish
SO  - Nagoya J Med Sci. 2018 May;80(2):175-182. doi: 10.18999/nagjms.80.2.175.